Skip to content

Using instrumented shoes in THA patients.

Clinical study on total hip arthroplasty patients with instrumented shoes.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29531
Enrollment
25
Registered
2011-05-17
Start date
2011-06-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Hip Arthroplasty Instrumented force shoes Ambulatory measurements Rehabilitation

Interventions

Patients undergoing THA will be measured before and 6-8 months after the operation. Both measurements include 3 functional mobility tasks while the subject is wearing instrumented force shoes (IFS). I

Sponsors

University of Twente
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 50 and 80 years; 2. Primary, unilateral, osteoarthritis of the hip; 3. Patients should be selected for a primary THA and undergo the operation within the next 4 months.

Exclusion criteria

Exclusion criteria: 1. Have bilateral THA; 2. Have any kind of leg arthroplasties; 3. Have rheumatoid arthritis; 4. Have any neurological disorder; 5. Not able to perform the tasks because of pain or impairment; 6. Suffering also from other degenerative diseases; 7. Develop a bilateral disease; 8. Revision/re-operations of primary hip prosthesis; 9. Unable to understand instructions or the questionnaire.

Design outcomes

Primary

MeasureTime frame
The first aim of this study is to investigate whether the IFS is a sufficiently sensitive instrument to show differences in mobility performance between before and after THA.

Secondary

MeasureTime frame
The second objective is to compare the IFS parameters to the gait velocity (assessed independently from the IFS) and questionnaire outcomes.

Contacts

Public ContactA. Martinez

Universiteit Twente. Biomedische Signalen en Systemen. Postbus 217.

A.Martinez@ewi.utwente.nl+ 31(0)53 4892765(2760)

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)